Press Conference

Recent Media Coverage

Read recent articles about PerkinElmer below. Clicking a headline will take you to the publication’s website for the full article.

Perkin Elmer Opens Medical Lab in Suzhou

This new facility provides a comprehensive offering of lab services to hospitals and patients in China, supporting the prevention of birth defects in newborns and infectious disease in adults.

Protecting the food chain from food fraud

Food fraud is defined by the United Kingdom’s Food Standard Agency as date tampering or selling goods past their use-by date, packing and selling products with an unknown origin, deliberately mislabeling food like farmed salmon as being wild, or using stolen or poached animal meat.

Ligand-Binding Assays and the Determination of Biosimilarity

During biosimilar development, it is necessary to demonstrate that the physicochemical properties, efficacy, and safety (e.g., immunogenicity) of the biosimilar are similar to those of the targeted branded biologic.

The Clouds are Rolling in

Robert Roe investigates cloud and SaaS deployment models and the inherent flexibility and scalability they provide to users.

PerkinElmer Acquires Perten Instruments

US-based PerkinElmer, Inc. (NYSE: PKI) has completed its acquisition of Sweden-based analytical instruments supplier Perten Instruments Group AB. The deal is worth around USD 266m. Perten supplies instruments for quality control of food, grain, flour and feed.

Collaborators Seek Biomarkers to Evaluate Patient Selection for Cancer Immunotherapy

OncoSec Medical Inc, San Diego, a company developing DNA-based intratumoral cancer immunotherapies, recently announced a collaboration with PerkinElmer Inc and the University of California, Los Angeles (UCLA), to help researchers develop biomarker tests for evaluating a patient’s immune response to cancer.

PerkinElmer Meets 3Q Profit Forecasts

PerkinElmer Inc. (PKI) on Thursday reported third-quarter profit of $42.3 million. The results met Wall Street expectations. The average estimate of analysts surveyed by Zacks Investment Research was also for earnings of 57 cents per share.

PerkinElmer Boosts Lab IT Services with Ceiba Solutions Purchase

Ceiba’s managed services, certification, and informatics technologies will be integrated into PKI’s OneSource Lab IT portfolio, which includes lab computing, scientific application and data services, and computer systems validation.

Elements: A New Approach to Collaborative Science

Take a tour through Elements as PerkinElmer demonstrates this new platform. Share research results with colleagues globally, review comments, gather input, and explore the ways in which Elements can help you with your research effectively.

PerkinElmer Launches Optical Imaging System

Perkin Elmer has unveiled its Solaris quantitative optical molecular imaging system for use in small and large animal studies. The Solaris system can bridge molecular imaging research techniques to support potential clinical outcomes.

A Case for Co-Sourcing

After a generation of outsourcing services to lower-cost providers, smart companies now realize that they need to reassess this strategy. Outsourcing did lower costs in a time of need, but it came at a high price.

Informatics Fosters 'Science as a Service'

Several forces are bringing into focus a future that includes the democratization of data, where individuals will be evaluating, analyzing, and making decisions from an abundance of data that is delivered right into their hands.

SCID Previously Underdiagnosed in Infants with Fatal Infections

Severe combined immunodeficiency (SCID), a potentially life-threatening disorder affecting infants, is twice as common as previously believed, according to a new study that is the first to examine the impact of this newborn screening test.

Reflections on ChemDraw

ChemDraw, the software program used by chemists worldwide to draw molecular structures, was originally invented to save Dave and Sally Evans’s marriage.